273 related articles for article (PubMed ID: 21761156)
1. From oncoproteins/tumor suppressors to microRNAs, the newest therapeutic targets for pulmonary arterial hypertension.
Paulin R; Courboulin A; Barrier M; Bonnet S
J Mol Med (Berl); 2011 Nov; 89(11):1089-101. PubMed ID: 21761156
[TBL] [Abstract][Full Text] [Related]
2. Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension.
Paulin R; Meloche J; Jacob MH; Bisserier M; Courboulin A; Bonnet S
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1798-809. PubMed ID: 21890685
[TBL] [Abstract][Full Text] [Related]
3. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
Cheng G; Wang X; Li Y; He L
Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
[TBL] [Abstract][Full Text] [Related]
4. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
[TBL] [Abstract][Full Text] [Related]
5. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
Orriols M; Gomez-Puerto MC; Ten Dijke P
Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
[TBL] [Abstract][Full Text] [Related]
7. PIM1 (Moloney Murine Leukemia Provirus Integration Site) Inhibition Decreases the Nonhomologous End-Joining DNA Damage Repair Signaling Pathway in Pulmonary Hypertension.
Lampron MC; Vitry G; Nadeau V; Grobs Y; Paradis R; Samson N; Tremblay È; Boucherat O; Meloche J; Bonnet S; Provencher S; Potus F; Paulin R
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):783-801. PubMed ID: 31969012
[TBL] [Abstract][Full Text] [Related]
8. MiR-23a regulates the proliferation and migration of human pulmonary artery smooth muscle cells (HPASMCs) through targeting BMPR2/Smad1 signaling.
Zhang Y; Peng B; Han Y
Biomed Pharmacother; 2018 Jul; 103():1279-1286. PubMed ID: 29864909
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-124 suppresses the transactivation of nuclear factor of activated T cells by targeting multiple genes and inhibits the proliferation of pulmonary artery smooth muscle cells.
Kang K; Peng X; Zhang X; Wang Y; Zhang L; Gao L; Weng T; Zhang H; Ramchandran R; Raj JU; Gou D; Liu L
J Biol Chem; 2013 Aug; 288(35):25414-25427. PubMed ID: 23853098
[TBL] [Abstract][Full Text] [Related]
10. Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension.
West JD; Carrier EJ; Bloodworth NC; Schroer AK; Chen P; Ryzhova LM; Gladson S; Shay S; Hutcheson JD; Merryman WD
PLoS One; 2016; 11(2):e0148657. PubMed ID: 26863209
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension.
Nie X; Chen Y; Tan J; Dai Y; Mao W; Qin G; Ye S; Sun J; Yang Z; Chen J
Vascul Pharmacol; 2019 May; 116():24-35. PubMed ID: 28694128
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension.
Deng L; Blanco FJ; Stevens H; Lu R; Caudrillier A; McBride M; McClure JD; Grant J; Thomas M; Frid M; Stenmark K; White K; Seto AG; Morrell NW; Bradshaw AC; MacLean MR; Baker AH
Circ Res; 2015 Oct; 117(10):870-883. PubMed ID: 26311719
[TBL] [Abstract][Full Text] [Related]
13. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
[TBL] [Abstract][Full Text] [Related]
14. Nur77 suppresses pulmonary artery smooth muscle cell proliferation through inhibition of the STAT3/Pim-1/NFAT pathway.
Liu Y; Zhang J; Yi B; Chen M; Qi J; Yin Y; Lu X; Jasmin JF; Sun J
Am J Respir Cell Mol Biol; 2014 Feb; 50(2):379-88. PubMed ID: 24047441
[TBL] [Abstract][Full Text] [Related]
15. Implication of Inflammation and Epigenetic Readers in Coronary Artery Remodeling in Patients With Pulmonary Arterial Hypertension.
Meloche J; Lampron MC; Nadeau V; Maltais M; Potus F; Lambert C; Tremblay E; Vitry G; Breuils-Bonnet S; Boucherat O; Charbonneau E; Provencher S; Paulin R; Bonnet S
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1513-1523. PubMed ID: 28473439
[TBL] [Abstract][Full Text] [Related]
16. Signal transducers and activators of transcription-3/pim1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension.
Paulin R; Courboulin A; Meloche J; Mainguy V; Dumas de la Roque E; Saksouk N; Côté J; Provencher S; Sussman MA; Bonnet S
Circulation; 2011 Mar; 123(11):1205-15. PubMed ID: 21382889
[TBL] [Abstract][Full Text] [Related]
17. miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling.
Yang S; Banerjee S; Freitas Ad; Cui H; Xie N; Abraham E; Liu G
Am J Physiol Lung Cell Mol Physiol; 2012 Mar; 302(6):L521-9. PubMed ID: 22227207
[TBL] [Abstract][Full Text] [Related]
18. Role for miR-204 in human pulmonary arterial hypertension.
Courboulin A; Paulin R; Giguère NJ; Saksouk N; Perreault T; Meloche J; Paquet ER; Biardel S; Provencher S; Côté J; Simard MJ; Bonnet S
J Exp Med; 2011 Mar; 208(3):535-48. PubMed ID: 21321078
[TBL] [Abstract][Full Text] [Related]
19. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.
Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS
J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556
[TBL] [Abstract][Full Text] [Related]
20. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
